Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Atherosclerosis Risk in Communities Study Investigators.

[1]  J. Haapakoski,et al.  Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. , 2009, Acta medica Scandinavica. Supplementum.

[2]  M. Laakso,et al.  How good a marker is insulin level for insulin resistance? , 1993, American journal of epidemiology.

[3]  J. Cerhan,et al.  Body fat distribution and 5-year risk of death in older women. , 1993, JAMA.

[4]  K. Matthews,et al.  Environmental and familial contributions to insulin levels and change in insulin levels in middle-aged women. , 1992, JAMA.

[5]  N. Fujita,et al.  Hyperinsulinaemia and blood pressure in patients with insulinoma. , 1992, BMJ.

[6]  M. Farrer,et al.  Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[7]  M. Laakso,et al.  Asymptomatic atherosclerosis and insulin resistance. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[8]  K. Pyörälä.  Hyperinsulinaemia as predictor of atherosclerotic vascular disease: epidemiological evidence. , 1991, Diabete & metabolisme.

[9]  E. Ravussin,et al.  Racial differences in the relation between blood pressure and insulin resistance. , 1991, The New England journal of medicine.

[10]  P. Savage,et al.  Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. , 1990, Arteriosclerosis.

[11]  U. Smith,et al.  Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease , 1990, Journal of internal medicine.

[12]  E. Barrett-Connor,et al.  Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favoring atherosclerosis. , 1989, Arteriosclerosis.

[13]  E. Bonora,et al.  Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. , 1989, The New England journal of medicine.

[14]  T. G. Coleman,et al.  Does chronic hyperinsulinemia cause hypertension? , 1989, American journal of hypertension.

[15]  K. Wu,et al.  ARICHemostasis Study - I. Development of a Blood Collection and Processing System Suitable for Multicenter Hemostatic Studies , 1989, Thrombosis and Haemostasis.

[16]  A. Folsom,et al.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. , 1989, American journal of epidemiology.

[17]  A. Sharrett,et al.  Effect of blood collection and processing on radioimmunoassay results for apolipoprotein B in plasma. , 1988, Clinical chemistry.

[18]  M. Nattrass,et al.  8 Macrovascular disease and hyperinsulinaemia , 1988 .

[19]  M. Najjar,et al.  Anthropometric reference data and prevalence of overweight, United States, 1976-80. , 1987, Vital and health statistics. Series 11, Data from the National Health Survey.

[20]  B. Howard,et al.  Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.

[21]  M. Laakso,et al.  Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. , 1987, American journal of epidemiology.

[22]  F. Cambien,et al.  Body Mass, Blood Pressure, Glucose, and Lipids: Does Plasma Insulin Explain Their Relationships? , 1987, Arteriosclerosis.

[23]  G. Burke,et al.  Fasting plasma glucose and insulin levels and their relationship to cardiovascular risk factors in children: Bogalusa Heart Study. , 1986, Metabolism: clinical and experimental.

[24]  J. Skyler,et al.  Blood pressure, insulin, and glycemia in nondiabetic subjects. , 1986, The American journal of medicine.

[25]  M. Alessi,et al.  Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects. , 1986, Metabolism: clinical and experimental.

[26]  D. Mintz,et al.  The effects of hyperinsulinemia on arterial wall and peripheral muscle metabolism in dogs. , 1985, Metabolism: clinical and experimental.

[27]  A. Krolewski,et al.  Is Insulin the Link Between Hypertension and Obesity? , 1985, Hypertension.

[28]  G. Reaven,et al.  Insulin and blood pressure in obesity. , 1985, Hypertension.

[29]  H. Halkin,et al.  Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. , 1985, The Journal of clinical investigation.

[30]  B V Howard,et al.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.

[31]  G. Reaven,et al.  Relationship Between the Plasma Insulin Response to Oral Glucose and Insulin-stimulated Glucose Utilization in Normal Subjects , 1984, Diabetes.

[32]  R. Tarazi.  Pathophysiology of essential hypertension. Role of the autonomic nervous system. , 1983, The American journal of medicine.

[33]  L H Kuller,et al.  Plasma insulin and lipoprotein concentrations: an atherogenic association? , 1983, American journal of epidemiology.

[34]  J. Ziegenhorn,et al.  Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. , 1983, Clinical chemistry.

[35]  J E Frijters,et al.  A short questionnaire for the measurement of habitual physical activity in epidemiological studies. , 1982, The American journal of clinical nutrition.

[36]  G. Reaven,et al.  Diabetic Hypertriglyceridemia: Evidence for Three Clinical Syndromes , 1981, Diabetes.

[37]  R. Abbate,et al.  Changes of Platelet Function and Blood Clotting in Diabetes Mellitus , 1979, Thrombosis and Haemostasis.

[38]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[39]  M. Gertler,et al.  Covert diabetes mellitus in ischemic heart and cerebrovascular disease. , 1972, Geriatrics.

[40]  T. Welborn,et al.  Serum-insulin in essential hypertension and in peripheral vascular disease. , 1966, Lancet.

[41]  T. Miettinen,et al.  Plasma-insulin in coronary heart-disease: response to oral and intravenous glucose and to tolbutamide. , 1965, Lancet.

[42]  C. Hales,et al.  PLASMA-INSULIN CONCENTRATIONS AFTER MYOCARDIAL INFRACTION. , 1965, Lancet.

[43]  R. Stout,et al.  Insulin and atheroma. 20-yr perspective. , 1990, Diabetes care.

[44]  A. Fontbonne,et al.  Coronary heart disease mortality risk: plasma insulin level is a more sensitive marker than hypertension or abnormal glucose tolerance in overweight males. The Paris Prospective Study. , 1988, International journal of obesity.

[45]  W. Gruber,et al.  Reagent for the Enzymatic Determination of Serum Total Triglycerides with Improved Lipolytic Efficiency , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[46]  T. Welborn,et al.  Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia--13-year study. , 1983, Journal of chronic diseases.